1,411 results on '"Perlman, S"'
Search Results
152. Ex vivoculture of human fetal gonads: manipulation of meiosis signalling by retinoic acid treatment disrupts testis development
153. SU-D-303-01: Spatial Distribution of Bone Metastases In Metastatic Castrate-Resistant Prostate Cancer
154. TU‐G‐BRA‐07: Characterization of Tumor Proliferation During Successive Cycles of Anti‐Angiogenic Therapy Using [F‐18]FLT PET/CT
155. Oral cleanliness and gingival health among Special Olympics athletes in Europe and Eurasia
156. Molecular Biology and Evolution of Toroviruses
157. [13] Segregation of mitochondrial markers in yeast
158. Maternal Antibody-Modulated MHV-JHM Infection in C57BL/6 and BALB/c Mice
159. Nonstructural proteins of human coronavirus NL63
160. Attachment factor and receptor engagement of SARS coronavirus and human coronavirus NL63
161. Human coronavirus NL63 infection is associated with group
162. Reward-related neural activity and structure predict future substance use in dysregulated youth.
163. X chromosome drive in a widespread Palearctic woodland fly, Drosophila testacea.
164. OP28.04: More than a gut feeling: sonographic prenatal diagnosis of imperforate anus in a high risk population
165. P08.06: Fetal renal to abdominal ratio a constant measurement throughout gestation
166. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity
167. The malignant potential of endometrial polyps can be determined by incorporating the Endometrial Intraepithelial Neoplasia (EIN) classification
168. Prenatal Diagnosis of Fetal Ventriculomegaly: Agreement between Fetal Brain Ultrasonography and MR Imaging
169. Middle east respiratory syndrome coronavirus (MERS-CoV): Announcement of the coronavirus study group
170. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group.
171. Order Nidovirales
172. Family Coronaviridae
173. Health Disparities in New York City: Disparities in Breast, Colorectal and Cervical Cancers in New York City
174. Prevention of Cytotoxic T Cell Escape Using a Heteroclitic Subdominant Viral T Cell Determinant
175. Every smile is special: Healthy Athletes Special Smiles Program makes a difference
176. TU‐A‐WAB‐06: Evaluation of Articulated Registration and Application to Metastatic Bone Lesions Identification
177. Molecular Biology and Evolution of Toroviruses
178. Transcriptome analysis provides insight into venom evolution in a seed-parasitic wasp, Megastigmus spermotrophus.
179. The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia
180. Oculomotor and visual axis systems sparing in spinocerebellar ataxia type 13
181. Evaluation of Precompletion Annular Gas Leaks in a Marcellus Lateral
182. WE‐C‐BRA‐07: Assessment of Heterogeneous Treatment Response in Patients with Multiple Solid Tumors
183. Prior Molecular Diagnostic Accuracy and Age of Disease Onset Variation in the CRC-SCA, a Multicenter Study of Spinocerebellar Ataxias (S12.003)
184. Clinical Characteristics of Spinocerebellar Ataxias 1, 2, 3 and 6 (S12.002)
185. OP22.04: Can the “angle of progression” as measured in nulliparous women before the onset of labor predict mode of delivery?
186. SU-E-I-167: Impact of Peak SUV Definition on Quantification of Treatment Response
187. SU‐D‐BRC‐06: Multimodality Assessment of Response to Combined Chemoradiation and Anti‐Angiogenic Therapy with CuATSM‐PET, FLT‐PET, and Contrast‐Enhanced CT Imaging
188. SU‐E‐I‐176: Impact of Residual Activity and Clock Synchronization on Quantitative Treatment Response Assessment
189. Pharmacodynamic and pharmacokinetic characterization of tumor proliferation during acute sunitinib (SU) withdrawal.
190. Phase I pharmacodynamic trial of sequential sunitinib (SU) with bevacizumab (bev) in patients with renal cell carcinoma (mRCC) and other advanced solid malignancies.
191. Ataxia-Telangiectasia and variants
192. J13 Prescription usage for treatment of irritability, perseverative behaviors, and chorea in huntington's disease
193. Endosymbiont costs and benefits in a parasitoid infected with both Wolbachia and Cardinium
194. MO‐D‐204B‐03: Correlation of PET Images of Metabolism, Proliferation and Hypoxia to Characterize Tumor Phenotype in Patients with HNSCC
195. SU-GG-J-152: Assessment of Normal Tissue Response to Therapy Using FLT PET
196. MO‐D‐204B‐05: Effect of PET Image Reconstruction Parameters on Quantitative Treatment Response Assessment
197. MO‐D‐204B‐08: Classification and Characterization of Tumor Subpopulations Using Molecular Imaging
198. Phase I study of continuous MKC-1 (cMKC-1) in patients (pts) with advanced or metastatic solid malignancies using a modified time-to-event continual reassessment method (TITE-CRM) for dose assignment.
199. Concurrent assessment of vasculature and proliferative pharmacodynamics in patients treated with VEGFR TKI.
200. Characterization of proliferative rebound during drug holiday by FLT-PET imaging in patients treated with sunitinib (SU).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.